OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular subtypes of ALS are associated with differences in patient prognosis
Jarrett Eshima, Samantha O’Connor, Ethan Marschall, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 231

CD22 modulation alleviates amyloid β-induced neuroinflammation
Dihua Yu, Qingqing Zhang, Christian Fung, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Repetitive elements in aging and neurodegeneration
Katie E. Copley, James Shorter
Trends in Genetics (2023) Vol. 39, Iss. 5, pp. 381-400
Open Access | Times Cited: 39

MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review
Sadegh Ghaderi, Farzad Fatehi, Sanjay Kalra, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2023) Vol. 24, Iss. 7-8, pp. 572-588
Closed Access | Times Cited: 24

Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS
Francesco Limone, Daniel A. Mordes, Alexander Benavides Couto, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 984-997
Open Access | Times Cited: 13

Unraveling the Heterogeneity of ALS—A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials
Laura Tzeplaeff, Alexandra V. Jürs, Camilla Wohnrade, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 452-452
Open Access | Times Cited: 8

Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target
Lucas Caldi Gomes, Sonja Hänzelmann, Fabian Hausmann, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Transcriptomic profiling of symptomatic and end-stage SOD1-G93A transgenic mice reveals extracellular matrix components as key players in ALS pathogenesis
Simona Rossi, M Milani, Ilaria Della Valle, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167707-167707
Open Access | Times Cited: 1

Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Chiara F. Valori, Claudia Sulmona, Liliana Brambilla, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1450-1450
Open Access | Times Cited: 19

Microglia pack a toolbox for life
Kristine E. Zengeler, John R. Lukens
Trends in Immunology (2024) Vol. 45, Iss. 5, pp. 338-345
Closed Access | Times Cited: 7

Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data
Heather Marriott, Renata Kabiljo, Guy P Hunt, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 13

Epigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosis
Yue Zhao, Xiayan Li, Kai Wang, et al.
EBioMedicine (2024) Vol. 109, pp. 105383-105383
Closed Access | Times Cited: 4

ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers
Kathryn O’Neill, Regina Shaw, Isobel Bolger, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115402-115402
Open Access

Neuroglia in neurodegeneration: Amyotrophic lateral sclerosis and frontotemporal dementia
Fabiola De Marchi, Edoardo Gioele Spinelli, Caterina Bendotti
Handbook of clinical neurology (2025), pp. 45-67
Closed Access

Exploring CSF biomarkers in amyotrophic lateral sclerosis: Highlighting the significance of TDP-43
Yih-Chih Kuo, Chih-Chao Yang, Li‐Kai Tsai
Journal of the Neurological Sciences (2025), pp. 123479-123479
Closed Access

Multiomics approach identifies SERPINB1 as candidate progression biomarker for Spinocerebellar Ataxia type 2
Luis E. Almaguer-Mederos, Jana Key, Nihat Şen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis
Korina Karagianni, Dimitra Dafou, Konstantinos Xanthopoulos, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3

Loss of amyotrophic lateral sclerosis risk factor SCFD1 causes motor dysfunction in Drosophila
Rebecca Borg, Angie Purkiss, Rebecca Cacciottolo, et al.
Neurobiology of Aging (2023) Vol. 126, pp. 67-76
Closed Access | Times Cited: 8

Distinct neuroinflammatory signatures exist across genetic and sporadic amyotrophic lateral sclerosis cohorts
Olivia M. Rifai, Judi O’Shaughnessy, Owen Dando, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 5124-5138
Open Access | Times Cited: 5

Data‐independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis
Elizabeth R. Dellar, Iolanda Vendrell, Kevin Talbot, et al.
Journal of Neurochemistry (2023) Vol. 168, Iss. 2, pp. 115-127
Open Access | Times Cited: 5

Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 158-158
Open Access | Times Cited: 1

Immune receptors and aging brain
Maja Djurišić
Bioscience Reports (2024) Vol. 44, Iss. 2
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top